Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Paulis, Leonie E ^a   Klein, Alexandra M ^b   Ghanem, Alexander ^b   Geelen, Tessa ^a   Coolen, Bram F ^a   Breitbach, Martin ^b   Zimmermann, Katrin ^b   Nicolay, Klaas ^a   Fleischmann, Bernd K ^b   Roell, Wilhelm ^b   Strijkers, Gustav J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOLUMINESCENCE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYO; EMBRYONIC CARDIOMYOCYTE TRANSPLANTATION; FLUORESCENCE IMAGING; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART OUTPUT; HEART VENTRICLE FUNCTION; LONG TERM SURVIVAL; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; SURVIVAL RATE;

ANIMALS; CARDIAC OUTPUT; CARDIOMYOPLASTY; EMBRYO, MAMMALIAN; GENES, REPORTER; INJECTIONS, INTRAMUSCULAR; LUCIFERASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; STROKE VOLUME; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR FUNCTION, LEFT;

MURINAE; MUS;

EID: 84876057291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061510     Document Type: Article

References (45)

1. Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, et al. (2001) Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 173: 75-82.
2. Segers VF, Lee RT, (2008) Stem-cell therapy for cardiac disease. Nature 451: 937-942.
3. Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, et al. (2002) Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 105: 2435-2441.
4. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, et al. (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450: 819-824.
5. Tang GH, Fedak PW, Yau TM, Weisel RD, Kulik A, et al. (2003) Cell transplantation to improve ventricular function in the failing heart. Eur J Cardiothorac Surg 23: 907-916.
6. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ, (2003) Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58: 336-350.
7. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, et al. (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110: 1362-1369.
8. Reinecke H, Poppa V, Murry CE, (2002) Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34: 241-249.
9. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, et al. (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54: 2277-2286.
10. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, et al. (2010) Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107: 913-922.
11. Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, et al. (1999) Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiov Sur 118: 715-724.
12. Ross AJ, Yang Z, Berr SS, Gilson WD, Petersen WC, et al. (2002) Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction. Magn Reson Med 47: 1158-1168.
13. Yang Z, Berr SS, Gilson WD, Toufektsian MC, French BA, (2004) Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 109: 1161-1167.
14. Roell W, Fan Y, Xia Y, Stoecker E, Sasse P, et al. (2002) Cellular cardiomyoplasty in a transgenic mouse model. Transplantation 73: 462-465.
15. Fleischmann M, Bloch W, Kolossov E, Andressen C, Muller M, et al. (1998) Cardiac specific expression of the green fluorescent protein during early murine embryonic development. FEBS Lett 440: 370-376.
16. Heijman E, Aben JP, Penners C, Niessen P, Guillaume R, et al. (2008) Evaluation of manual and automatic segmentation of the mouse heart from CINE MR images. J Magn Reson Imaging 27: 86-93.
17. Buller VG, van der Geest RJ, Kool MD, van der Wall EE, de Roos A, et al. (1997) Assessment of regional left ventricular wall parameters from short axis magnetic resonance imaging using a three-dimensional extension to the improved centerline method. Invest Radiol 32: 529-539.
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, et al. (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Journal of Nuclear Cardiology 9: 240-245.
19. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, et al. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 1: 9-24.
20. Strijkers GJ, Bouts A, Blankesteijn WM, Peeters TH, Vilanova A, et al. (2009) Diffusion tensor imaging of left ventricular remodeling in response to myocardial infarction in the mouse. NMR Biomed 22: 182-190.
21. van Laake LW, Passier R, Doevendans PA, Mummery CL, (2008) Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 102: 1008-1010.
22. van der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, et al. (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118: S121-S129.
23. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, et al. (2009) Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 87: 642-652.
24. Gaudette GR, Cohen IS, (2006) Cardiac regeneration-Materials can improve the passive properties of myocardium, but cell therapy must do more. Circulation 114: 2575-2577.
25. Qiao H, Zhang HL, Yamanaka S, Patel VV, Petrenko NB, et al. (2011) Long-Term Improvement in Postinfarct Left Ventricular Global and Regional Contractile Function Is Mediated by Embryonic Stem Cell-Derived Cardiomyocytes. Circ Cardiovasc Imaging 4: 33-U53.
26. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, et al. (2007) Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116: I46-54.
27. Li Z, Lee A, Huang M, Chun H, Chung J, et al. (2009) Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol 53: 1229-1240.
28. Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, et al. (2009) Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med 50: 1088-1094.
29. Li Z, Suzuki Y, Huang M, Cao F, Xie X, et al. (2008) Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26: 864-873.
30. Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, et al. (2007) Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116: I38-45.
31. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, et al. (2003) Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108: 1009-1014.
32. Winter EM, Grauss RW, Atsma DE, Hogers B, Poelmann RE, et al. (2008) Left ventricular function in the post-infarct failing mouse heart by magnetic resonance imaging and conductance catheter: a comparative analysis. Acta Physiol (Oxf) 194: 111-122.
33. Ghanem A, Troatz C, Elhafi N, Dewald O, Heeschen C, et al. (2008) Quantitation of myocardial borderzone using reconstructive 3-D echocardiography after chronic infarction in rats-Incremental value of low-dose dobutamine. Ultrasound in Medicine and Biology 34: 559-566.
34. Stegger L, Heijman E, Schafers KP, Nicolay K, Schafers MA, et al. (2009) Quantification of left ventricular volumes and ejection fraction in mice using PET, compared with MRI. J Nucl Med 50: 132-138.
35. Arai T, Kofidis T, Bulte JW, De Bruin J, Venook RD, et al. (2005) Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5T. Magn Reson Med 55: 203-209.
36. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, et al. (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127: 213-223.
37. Xiong Q, Ye L, Zhang P, Lepley M, Tian J, et al. (2013) Functional Consequences of Human Induced Pluripotent Stem Cells Therapy: Myocardial ATP Turnover Rate in the in vivo Swine Hearts with Post-Infarction Remodeling. Circulation.
38. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM, (2006) Theoretical impact of the injection of material into the myocardium-A finite element model simulation. Circulation 114: 2627-2635.
39. Liu J, Narsinh KH, Lan F, Wang L, Nguyen PK, et al. (2012) Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging. Circ Cardiovasc Imaging 5: 481-490.
40. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B, (1988) Cellular mechanisms of myocardial infarct expansion. Circulation 78: 186-201.
41. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, et al. (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325.
42. Jackson BM, Gorman JH, Moainie SL, Guy TS, Narula N, et al. (2002) Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol 40: 1160-1167; discussion 1168-1171.
43. Sasse P, Malan D, Fleischmann M, Roell W, Gustafsson E, et al. (2008) Perlecan is critical for heart stability. Cardiovasc Res 80: 435-444.
44. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083.
45. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10: 494-501.